← Chemours Co
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $5.4b | $6.2b | $6.6b | $5.5b | $5.0b | $6.3b | $6.8b | $6.0b | $5.8b | $5.8b | |
| Cost of Revenue | $4.3b | $4.4b | $4.7b | $4.5b | $3.9b | $5.0b | $5.2b | $4.7b | $4.6b | $4.9b | |
| Gross Profit | $1.1b | $1.8b | $2.0b | $1.1b | $1.1b | $1.4b | $1.6b | $1.3b | $1.2b | $902.0m | |
| Operating Expenses | $1.2b | $739.0m | $788.0m | $715.0m | $700.0m | $705.0m | $844.0m | $1.6b | $810.0m | $966.0m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | — | — | — | — | — | — | — | — | $1.0m | $1.0m | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $56.0m | $0 | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($481.0m) | ($306.0m) | $114.0m | ($375.0m) | ($136.0m) | $44.0m | $217.0m | ($638.0m) | ($199.0m) | ($453.0m) | |
| Income (Loss) from Equity Method Investments | $29.0m | $33.0m | $43.0m | $29.0m | $23.0m | $43.0m | $55.0m | $45.0m | $43.0m | $35.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($11.0m) | $912.0m | $1.2b | ($124.0m) | $179.0m | $676.0m | $741.0m | ($318.0m) | $127.0m | ($277.0m) | |
| Net Income (Loss) Attributable to Parent | $7.0m | $746.0m | $995.0m | ($52.0m) | $219.0m | $608.0m | $578.0m | ($238.0m) | $86.0m | ($386.0m) | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $0 | $1.0m | $1.0m | $0 | $0 | — | — | ($1.0m) | — | — | |
| Earnings Per Share, Basic | $0.04 | $4.04 | $5.62 | ($0.32) | $1.33 | $3.69 | $3.72 | ($1.60) | $0.58 | ($2.57) | |
| Earnings Per Share, Diluted | $0.04 | $3.91 | $5.45 | ($0.32) | $1.32 | $3.60 | $3.65 | ($1.60) | $0.57 | ($2.57) | |
| Common Stock, Dividends, Per Share, Declared | — | — | — | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $0.51 | |
| Weighted Average Number of Shares Outstanding, Basic | 181.6m | 184.8m | 177.0m | 164.8m | 164.7m | 164.9m | 155.4m | 148.9m | 149.5m | 150.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | 183.4m | 191.0m | 182.6m | 164.8m | 166.3m | 168.7m | 158.3m | 148.9m | 150.2m | 150.2m | |
| Selling, General and Administrative Expense | $934.0m | $602.0m | $657.0m | $548.0m | $527.0m | $592.0m | $710.0m | $1.3b | $585.0m | $799.0m | |
| Other Nonoperating Income (Expense) | $247.0m | $79.0m | $162.0m | ($293.0m) | $21.0m | $163.0m | $70.0m | $91.0m | $8.0m | $26.0m | |
| Current Income Tax Expense (Benefit) | $93.0m | $82.0m | $137.0m | $91.0m | $80.0m | $144.0m | $143.0m | $77.0m | $68.0m | $49.0m | |
| Environmental Remediation Expense | $44.0m | $48.0m | $36.0m | $200.0m | $71.0m | $269.0m | $269.0m | $66.0m | $70.0m | $123.0m | |
| Interest Expense | $213.0m | $215.0m | $195.0m | $208.0m | $210.0m | $185.0m | $163.0m | $208.0m | $264.0m | $269.0m | |
| Other Cost and Expense, Operating | — | — | $1.0m | — | — | — | — | — | — | — | |
| Research and Development Expense | $80.0m | $80.0m | $82.0m | $80.0m | $93.0m | $107.0m | $118.0m | $108.0m | $109.0m | $108.0m | |
| Income Tax Expense (Benefit) | ($18.0m) | $165.0m | $159.0m | ($72.0m) | ($40.0m) | $68.0m | $163.0m | ($81.0m) | $41.0m | $109.0m | |
| Interest Income (Expense), Net | ($213.0m) | ($215.0m) | ($195.0m) | ($208.0m) | — | — | — | — | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.